Related references
Note: Only part of the references are listed.Sequence-dependent abnormal aggregation of human Tau fragment in an inducible cell model
Xiao-Ling Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjects
Jon B. Toledo et al.
BRAIN (2015)
Cellular Models of Aggregation-dependent Template-directed Proteolysis to Characterize Tau Aggregation Inhibitors for Treatment of Alzheimer Disease
Charles R. Harrington et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Tau Proteins in the Temporal and Frontal Cortices in Patients With Vascular Dementia
Elizabeta B. Mukaetova-Ladinska et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2015)
Arizona Study of Aging and Neurodegenerative Disorders and Brain and Body Donation Program
Thomas G. Beach et al.
NEUROPATHOLOGY (2015)
Association of Pituitary Adenylate Cyclase-Activating Polypeptide With Cognitive Decline in Mild Cognitive Impairment Due to Alzheimer Disease
Pengcheng Han et al.
JAMA NEUROLOGY (2015)
Cerebrospinal Fluid Markers of Neurodegeneration and Rates of Brain Atrophy in Early Alzheimer Disease
Rawan Tarawneh et al.
JAMA NEUROLOGY (2015)
Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle Age
Courtney L. Sutphen et al.
JAMA NEUROLOGY (2015)
PET imaging of tau pathology in Alzheimer's disease and tauopathies
Olga G. James et al.
FRONTIERS IN NEUROLOGY (2015)
Longitudinal Assessment of Tau Pathology in Patients with Alzheimer's Disease Using [18F] THK-5117 Positron Emission Tomography
Aiko Ishiki et al.
PLOS ONE (2015)
Exosomes: Mediators of Neurodegeneration, Neuroprotection and Therapeutics
Anuradha Kalani et al.
MOLECULAR NEUROBIOLOGY (2014)
Cerebrospinal fluid sphingolipids, β-amyloid, and tau in adults at risk for Alzheimer's disease
Michelle M. Mielke et al.
NEUROBIOLOGY OF AGING (2014)
The importance of tau phosphorylation for neurodegenerative diseases
Wendy Noble et al.
FRONTIERS IN NEUROLOGY (2013)
Correlation of Amyloid PET Ligand Florbetapir F 18 Binding With Aβ Aggregation and Neuritic Plaque Deposition in Postmortem Brain Tissue
Seok Rye Choi et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2012)
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study (vol 11, pg 669, 2012)
C. M. Clark et al.
LANCET NEUROLOGY (2012)
Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
Christopher M. Clark et al.
LANCET NEUROLOGY (2012)
Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial
Khalid Iqbal et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
Cerebrospinal fluid total tau as a marker of Alzheimer's disease intensity
Kaisa Samgard et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Mechanisms of tau-induced neurodegeneration
Khalid Iqbal et al.
ACTA NEUROPATHOLOGICA (2009)
Early Diagnosis of Alzheimer's Disease: Is MCI Too Late?
Ronald C. Petersen
CURRENT ALZHEIMER RESEARCH (2009)
NAP protects memory, increases soluble tau and reduces tau hyperphosphorylation in a tauopathy model
Natalia Shiryaev et al.
NEUROBIOLOGY OF DISEASE (2009)
MRI and CSF biomarkers in normal, MCI, and AD subjects Diagnostic discrimination and cognitive correlations
P. Vemuri et al.
NEUROLOGY (2009)
MRI and CSF biomarkers in normal, MCI, and AD subjects Predicting future clinical change
P. Vemuri et al.
NEUROLOGY (2009)
Tau in cerebrospinal fluid: A sensitive sandwich enzyme-linked immunosorbent assay using tyramide signal amplification
Hidenaga Yamamori et al.
NEUROSCIENCE LETTERS (2007)
Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms
C Andorfer et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Share Paper
